The monoamine oxidase inhibitory effect of new homopyrimidazole derivatives.
D000588:Amines / Q000378:metabolism; D000818:Animals; D001593:Benzyl Compounds / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D002250:Carbon Radioisotopes; D003864:Depression, Chemical; D008297:Male; D008928:Mitochondria / Q000187:drug effects* / Q000201:enzymology; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010080:Oxazoles / Q000494:pharmacology; D010084:Oxidation-Reduction; D010880:Piperidines / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011744:Pyrimidinones / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014439:Tyramine / Q000378:metabolism
D000588:Amines; D001593:Benzyl Compounds; D002250:Carbon Radioisotopes; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D010880:Piperidines; D011725:Pyridines; D011744:Pyrimidinones; D014316:Tritium; D012701:Serotonin; D014439:Tyramine